头颈癌适形与调强放疗后的局部区域复发模式
研究纳入2007至2013年间接受根治性或术后3D CRT或IMRT的112例头颈癌患者中的26例复发者,将复发CT与原发CT刚性配准,评估复发体积与原发靶区的重叠及复发位置。结果显示多数失败发生在完成原发治疗后1年内,15/26例复发位于原发靶区或 elective 淋巴引流区内的区域淋巴结,多数复发被判定为野内复发,且与治疗方式无关。作者认为复发原因可能与原发治疗总剂量不足和/或初始诊断不充分导致靶区勾画不准确有关。
要点
- 多数复发发生在完成原发治疗后1年内
- 15/26例复发位于原发靶区或 elective 淋巴引流区内的区域淋巴结
- 多数复发为野内复发,与IMRT或3D CRT无关
核心结论
- 多数患者复发发生在高剂量区的区域淋巴结,原因可能为原发治疗总剂量不足和/或初始诊断不充分导致靶区勾画不准确。
研究设计与样本
- 回顾性纳入2007至2013年间接受根治性或术后3D CRT或IMRT的头颈癌患者112例中的26例复发者,将复发CT与原发CT刚性配准分析复发体积与原发靶区重叠及复发位置。
主要发现
- 多数失败发生在完成原发治疗后1年内。
- 15/26例复发发生在完全或部分位于原发靶区或 elective 淋巴引流区内的区域淋巴结。
- 多数复发被判定为野内复发,与 primary treatment 无关。
- 复发体积剂量差异在IMRT与3D CRT治疗患者间无统计学意义。
临床怎么用
- 头颈癌放疗后1年内需密切随访监测局部区域复发。
- 靶区勾画时应确保区域淋巴结覆盖充分并保证足够的总剂量。
局限性
- 样本量较小,仅纳入26例复发患者。
- 为回顾性分析,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To evaluate the patterns of loco-regional recurrences in head and neck cancer patients METHODS: Twenty-six out of 112 patients treated with primary or postoperative 3D CRT or IMRT for their primary and recurrent disease between 2007 and 2013 were included. The CT images of recurrent disease were rigidly registered with the primary CT images for each patient. To assess overlaps and overlap localization, the recurrence volume overlapping with the primary target volume was identified. For relapses occurring in the regional lymph nodes, the epicenter distance in recurrences and primary volumes and dose in recurrences were also identified. The recurrences were defined as in-field, marginal or out-of-field. RESULTS: The majority of the failures occurred within 1 year after completed primary treatment. The dose differences in recurrence volume were not statistically significant when patients were treated with IMRT or 3D CRT. Recurrence in 15/26 of the included patients occurred in the regional lymph nodes located fully or partly inside the primary target volume or the elective lymph node region. The majority of recurrences were recognized as in-field, independent of the primary treatment. CONCLUSION: Recurrence in the majority of the patients occurred in the regional lymph nodes located in high dose area. The cause of recurrence may be due to inadequate total dose in the primary treatment and/or lack of optimal primary diagnosis leading to inadequate primary target delineation.
引用
- Johansen S, Norman MH, Dale E, et al. Patterns of local-regional recurrence after conformal and intensity-modulated radiotherapy for head and neck cancer. Radiat Oncol. 2017. PMID: 28545588. doi:10.1186/s13014-017-0829-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。